Jemperli

News

GSK to file Jemperli for rectal cancer after phase 3 readout

GSK's pivotal AZUR-1 trial of Jemperli monotherapy to delay or eliminate surgery in pre-operative rectal cancer has delivered a positive result.

Oncology

ASCO 2026: A potential functional cure in endometrial cancer...

For GSK, ASCO 2026 was about long-term follow-up data, with new data from ongoing trials of Jemperli and Blenrep.

News

GSK/Tesaro claim denied in Jemperli lawsuit with AnaptysBio

A court ruling in the US has delivered a setback for GSK and its Tesaro subsidiary in their dispute with AnaptysBio over cancer drug Jemperli.

News

Gloved hand punches a karate pad held up

GSK unit and AnaptysBio trade lawsuits over Jemperli

A spat between GSK/Tesaro and AnaptysBio over cancer drug Jemperli has escalated into litigation, with both parties claiming breach of contract.

News

EU approves endometrial, lung cancer drugs from GSK and J&J

Both GSK and J&J have claimed pivotal approvals for growth-phase oncology therapies in the EU.

News

GSK bags sought-after Jemperli okay in endometrial cancer

The FDA has cleared GSK's PD-1 inhibitor Jemperli as a treatment for all adult patients with primary advanced or recurrent endometrial cancer, a key part of the company's growth ambitions f

GSK to file Jemperli for rectal cancer after phase 3 readout

ASCO 2026: A potential functional cure in endometrial cancer...

GSK/Tesaro claim denied in Jemperli lawsuit with AnaptysBio

GSK unit and AnaptysBio trade lawsuits over Jemperli

EU approves endometrial, lung cancer drugs from GSK and J&J

GSK bags sought-after Jemperli okay in endometrial cancer

Lundbeck preps for key bexicaserin data around year-end

Discover a new era of healthcare panel engagement: Grounded ...

Jemperli

Editor's Picks